Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study-Reference-Cited by-同舟云学术

Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study

Published:2019-04-13 Issue:6 Volume:85 Page:1337-1347
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Phrommintikul Arintaya¹²³^ORCID,Wongcharoen Wanwarang¹²³,Kumfu Sirinart²³⁴,Jaiwongkam Thidarat²³⁴,Gunaparn Siriluck¹,Chattipakorn Siriporn²³⁵^ORCID,Chattipakorn Nipon²³⁴

Affiliation:

1. Department of Internal Medicine, Faculty of MedicineChiang Mai University Chiang Mai Thailand

2. Cardiac Electrophysiology Research and Training Center, Faculty of MedicineChiang Mai University Chiang Mai Thailand

3. Center of Excellence in Cardiac Electrophysiology ResearchChiang Mai University Chiang Mai Thailand

4. Cardiac Electrophysiology Unit, Department of Physiology, Faculty of MedicineChiang Mai University Chiang Mai Thailand

5. Department of Oral Biology and Diagnostic Sciences, Faculty of DentistryChiang Mai University Chiang Mai Thailand

Funder

Thailand Research Fund

National Science and Technology Development Agency

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13903

Reference43 articles.

1. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

2. Excess Mortality among Persons with Type 2 Diabetes

3. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

4. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

5. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Dapagliflozin Dosing on Low‐Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta‐Analysis;The Journal of Clinical Pharmacology;2024-08

2. Effect of dipeptidyl peptidase-4 inhibitors on tumor necrosis factor alpha levels in patients with type 2 diabetes mellitus;European Journal of Medical Research;2024-07-12

3. The current landscape for diabetes treatment: Preventing diabetes-associated CV risk;Atherosclerosis;2024-07

4. The effect of sodium‐glucose cotransporter‐2 inhibitors on inflammatory biomarkers: A meta‐analysis of randomized controlled trials;Diabetes, Obesity and Metabolism;2024-04-11

5. Comparison of cardiovascular outcomes of new antihyperglycemic agents in Type 2 Diabetes Mellitus: a meta‐analysis;ESC Heart Failure;2024-02-28